The Biology of Bone Grafting

J Am Acad Orthop Surg · 2005 · Classic · cited 856 times

Safdar N. Khan, Frank P. Cammisa, Harvinder S. Sandhu, Ashish D. Diwan, Federico P. Girardi, Joseph M. Lane

General Orthopaedics

SUMMARY — THE REDUCTIONReviews the biology and clinical use of bone grafts, noting autogenous cancellous bone remains the gold standard despite donor-site morbidity driving interest in alternatives.
Abstract, as published

Many approaches are used to repair skeletal defects in reconstructive orthopaedic surgery, and bone grafting is involved in virtually every procedure. The type of bone graft used depends on the clinical scenario and the anticipated final outcome. Autogenous cancellous bone graft, with its osteogenic, osteoinductive, and osteoconductive properties, remains the standard for grafting. However, the high incidence of morbidity during autogenous graft harvest may make the acquisition of grafts from other sources desirable. The clinical applications for each type of bone graft are dictated by the structure and biochemical properties of the graft. An elegant cellular and molecular cascade follows bone transplantation. Bone graft incorporation within the host, whether autogenous or allogeneic, depends on many factors: type of graft (autogenous versus allogeneic, vascular versus nonvascular), site of transplant, quality of transplanted bone and host bone, host bed preparation, preservation techniques, systemic and local disease, and mechanical properties of the graft.

Featured in the 2026-09-02 issue.

← Effect of Ambient Listening Technology on E&M Codes in Orthop…Governmental Regulations and Increasing Food and Drug Adminis… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.